Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015

Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )
17 Jun 2015

EHA 2015 highlights

Peter Goodwin - ecancer reporter
EHA 2015 highlights ( Peter Goodwin - ecancer reporter )
17 Jun 2015

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015

Biomarkers for childhood relapsed acute lymphoblastic leukaemia

Prof Anthony Moorman - Newcastle University, Newcastle, UK
Biomarkers for childhood relapsed acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
16 Jun 2015

Are CML patients being treated to the correct standard?

Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany
Are CML patients being treated to the correct standard? ( Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany )
16 Jun 2015

PDL1 expression in thymic tumours

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
PDL1 expression in thymic tumours ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
16 Jun 2015

Exciting update on the Repurposing Drugs in Oncology (ReDO) project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Exciting update on the Repurposing Drugs in Oncology (ReDO) project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
15 Jun 2015

Overview of innovation in Hodgkin's lymphoma

Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award
Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )
14 Jun 2015

Applications of chimaeric antigen receptor T-cells in leukaemia

Dr Carl June - University of Pennsylvania, Philadelphia, USA
Applications of chimaeric antigen receptor T-cells in leukaemia ( Dr Carl June - University of Pennsylvania, Philadelphia, USA )
14 Jun 2015

Minimal residual disease in multiple myeloma

Dr Bruno Paiva - University Clinic of Navarra, Pamplona, Spain
Minimal residual disease in multiple myeloma ( Dr Bruno Paiva - University Clinic of Navarra, Pamplona, Spain )
14 Jun 2015

Immunoconjugates address unmet needs in Hodgkin's lymphoma patients

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands
Immunoconjugates address unmet needs in Hodgkin's lymphoma patients ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )
13 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation